A semi-autonomous robot synthetic biologist for industrial biodesign and manufacturing

Lead Research Organisation: Imperial College London
Department Name: Life Sciences

Abstract

The last decade has seen significant advances in the fields of synthetic biology as well as robotics and artificial intelligence (AI). Synthetic biology is an emerging multidisciplinary field with potential to have step-change benefits in many fields from medicine through to industrial biotechnology. This advance is dependent on the ability to rationally engineer biological organisms in a more predictable and defined way than has previously been possible.

Bio-manufacturing is an increasingly important platform for a sustainable manufacturing future. Many natural products have potentially valuable nutraceutical or pharmaceutical applications, but cannot be chemically synthesised or harvested from nature without significant ecological disruption. The engineering of biology by design seeks to construct new biological entities that are optimised for specific functionality such as bio-production within a 'cellular factory'. Synthetic biology provides a method for optimising production of complex natural products using sustainable methods in a microbial production host, much like ethanol is produced in yeast. Advanced synthetic biology tools will enable us to tackle more complex targets. Here, by integrating synthetic biology tools with robotics and AI we aim to make a significant advance to reducing the cost and development time of new biologically derived products.

It is now evident that robotics is essential for synthetic biology to fulfil its potential and is of particular relevance to industrial biotechnology. In parallel, big data has become increasingly important in many areas of technology as well as the biological domain. This is leading to new and powerful applications of AI in everyday life. Here we seek to address the application of AI to synthetic biology, using AI approaches to direct automated synthetic biology experiments.

These advances will have the potential to create new products, companies and even industries that will ultimately benefit the economy, health, quality of life and security of the UK general public and beyond. It will also have far-reaching effects on policy and society.

Planned Impact

The last decade has seen significant advances in the fields of synthetic biology as well as robotics and AI. Synthetic biology is an emerging multidisciplinary field with potential to have step-change benefits in many fields from medicine through to industrial biotechnology and defence/security. This advance is dependent on the ability to rationally engineer biological organisms in a more predictable and defined way than has previously been possible. It is now evident that robotics is essential for synthetic biology to fulfil its potential and is of particular relevance to industrial biotechnology. In parallel, big data has become increasingly important in many areas of technology, including the biological domain. This is leading to new and powerful applications of AI in everyday life. Here we seek to address the application of AI to synthetic biology, using machine learning approaches to direct automated synthetic biology experiments. This will have important and potentially far reaching applications in the industrialisation of synthetic biology tools and processes. These advances will have the potential to create new products, companies and even industries that will ultimately benefit the economy, health, quality of life and security of the UK general public and beyond. It will also have far-reaching effects on policy and society.

Publications

10 25 50
 
Description A platform for automated DNA assembly has been created.
We are developing a novel Inductive Learning approach that aims to bridge between symbolic learning and and numerical models. This novel approach is required to provide an abductive learning framework that can be applied to noisy experimental data.
Exploitation Route AI is an important and growing area of research and the approaches we are developing may be applicable to many other fields.

The practical developments in experimental synthetic biology through the building of auotmated approaches is key to the advancement of the field. The low cost approach that we have taken is enabling across a wide diversity of research and industrial applications.
Sectors Agriculture, Food and Drink,Chemicals,Manufacturing, including Industrial Biotechology

 
Description 21EBTA: EB-AI consortium for bioengineered cells and systems (AI-4-EB)
Amount £1,554,946 (GBP)
Funding ID BB/W013770/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 01/2022 
End 01/2024
 
Title Automated DNA Assembly 
Description We have automated BASIC DNA assembly to enable high throughput and scaleable assembly of new DNA constructs 
Type Of Material Technology assay or reagent 
Year Produced 2019 
Provided To Others? Yes  
Impact Since putting a prepring of our paper on BioRxiv we have had more than 900 pdf downloads 
URL https://www.biorxiv.org/content/10.1101/832139v1
 
Description CCBio 
Organisation CC Biotech
Country United Kingdom 
Sector Private 
PI Contribution Expertise in engineering of microbial organisms and automated DNA assembly
Collaborator Contribution Automated DNA assembly
Impact none
Start Year 2021
 
Description Neobe Therapeutics 
Organisation Neobe Therapeutics Ltd
Country United Kingdom 
Sector Private 
PI Contribution Expertise in microbial engineering Automated DNA assembly
Collaborator Contribution Therapeutic approaches to cancer treatment.
Impact none
Start Year 2021
 
Title DNABOT Software 
Description Software that drives our automated DNA assembly process 
Type Of Technology Software 
Year Produced 2019 
Open Source License? Yes  
Impact Since we published this work in BioRxiv it has been downloaded more than 900 times. 
URL https://github.com/BASIC-DNA-ASSEMBLY/DNA-BOT